tryptanthrine has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, KN; Liao, X; Mak, NK; Zhou, X | 1 |
| Anto, RJ; Antony, J; Chandran, H; Joseph, SM; Katiki, MR; Murty, MS; Nath, LR; Nishanth, KS; Panakkal, EJ; Paul, A; Rajan, E; Ran, S; Saikia, M; Sankar, S; Shabna, A; Sridivya, I; Sriramya, I; Vinod, V | 1 |
2 other study(ies) available for tryptanthrine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway.
Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Proliferation; Drugs, Chinese Herbal; Endothelial Cells; Humans; MAP Kinase Signaling System; Mice; Neovascularization, Pathologic; Quinazolines; Vascular Endothelial Growth Factor Receptor-2; Wound Healing | 2013 |
DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apocynaceae; Apoptosis; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Disease Models, Animal; Humans; Melanoma; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Neovascularization, Pathologic; Plant Extracts; Plant Leaves; Quinazolines; Signal Transduction; Xenograft Model Antitumor Assays | 2015 |